NEUROENDOCRINE REGULATION OF BONE-FAT CROSSTALK IN OBESITY
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS San Raffaele
About this trial
To study the effect of neuroendocrine dysfunctions on bone health in obesity
Eligibility criteria
Qualifiers
Male and female subject > 18-year-old (also fertile patients can be included)
Patients with prolactinoma or Cushing disease, Acromegaly or hypogonadism/hypopituitarism
BMI ≥30 Kg/m2
Able to sign an informed consent
Disqualifiers
Male and female subject <18-year-old
pregnant or breastfeeding women
Subject unable to sign informed consent
BMI < 30 Kg/m2
Trial design
Treatments tested in this trial
- Dexa or Biompedance analysis with clinical and biochemical evaluations
Treatment groups
150 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
IRCCS San Raffaele
Lead sponsor
Federico II University
Collaborator
University of Catanzaro
Collaborator
Istituto Auxologico Italiano
Collaborator
Source ClinicalTrials.gov